Cerebral phaeohyphomycosis caused by Fonsecaea monophora

Medical Mycology

Volumn 43, Issue 5, 2005, Pages 465-472

  Surash, S ^a   Tyagi, A ^a   de Hoog, G S ^b   Zeng, J S ^b   Barton, R C ^a   Hobson, Richard P ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

Author keywords

Brain; Cerebral; Fonsecaea; Infection; Phaeohyphomycosis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ADULT; ARTICLE; BRAIN ABSCESS; BRAIN INFECTION; CASE REPORT; CHROMOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; FONSECAEA; FONSECAEA MONOPHORA; FONSECAEA PEDROSOI; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENERAL CONDITION DETERIORATION; GENUS; HUMAN; IMMUNOCOMPETENCE; MALE; NEUROTROPISM; NEW SPECIES; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAEOHYPHOMYCOSIS; SPECIES DIFFERENCE;

ASCOMYCOTA; BRAIN ABSCESS; CHROMOBLASTOMYCOSIS; HUMANS; MALE; MIDDLE AGED; MYCOSES; TOMOGRAPHY, X-RAY COMPUTED;

FONSECAEA; FONSECAEA MONOPHORA; FONSECAEA PEDROSOI;

EID: 24644471895     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1080/13693780500220373     Document Type: Article

References (23)

1. Brandt ME, Warnock DW. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother 2003; 15(Suppl 2): 36-47.
2. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: A review of 101 cases. Clin Infect Dis 2004; 38: 206-216.
3. Horre R, de Hoog GS. Primary cerebral infections by melanized fungi: A review. Stud Mycol 1999; 43: 176-193.
4. Kantarcioglu AS, de Hoog GS. Infections of the central nervous system by melanized fungi: A review of cases presented between 1999 and 2004. Mycoses 2004; 47: 4-13.
5. de Hoog GS, Attili-Angekis D, Vicente VA, Gerrits Van Den Ende AHG. Molecular ecology and pathogenic potential of Fonsecaea species. Med Mycol 2004; 42: 405-416.
6. Nobrega JP, Rosemberg S, Adami AM, et al. Fonsecaea pedrosoi cerebral phaeohyphomycosis ("chromoblastomycosis"): First human culture-proven case reported in Brazil. Rev Inst Med Trop Sao Paulo 2003; 45: 217-220.
7. Hiruma M, Kawada A, Ohata H, et al. Systemic phaeohyphomycosis caused by Exophiala dermatitidis. Mycoses 1993; 36: 1-7.
8. Sutton DA, Slifkin M, Yakulis R, Rinaldi MG. U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): Criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J Clin Microbiol 1998; 36: 708-715.
9. Fukushiro R. Chromomycosis in Japan. Int J Dermatol 1983; 22: 221-229.
10. Matos T, de Hoog GS, de Boer AG, de C I, Haase G. High prevalence of the neurotrope Exophiala dermatitidis and related oligotrophic black yeasts in sauna facilities. Mycoses 2002; 45: 373-377.
11. de Hoog GS, Takeo K, Gottlich E, Nishimura K, Miyaji M. A human isolate of Exophiala (Wangiella) dermatitidis forming a catenate synanamorph that links the genera Exophiala and Cladophialophora. J Med Vet Mycol 1995; 33: 355-358.
12. Al-Hedaithy SS, Jamjoom ZA, Saeed ES. Cerebral phaeohyphomycosis caused by Fonsecaea pedrosoi in Saudi Arabia. APMIS Suppl 1988; 3: 94-100.
13. Campbell CK, Al-Hedaithy SSA. Phaeohyphomycosis of the brain caused by Ramichloridium mackenziei sp. nov. in Middle Eastern countries. J Med Vet Mycol 1993; 31: 325-332.
14. Lucasse C, Chardome J, Magis P. Cerebral mycosis from Cladosporium trichoides in a native of the Belgian Congo. Ann Soc Belg Med Trop 1954; 34: 475-478.
15. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000; 13: 236-301.
16. Lirng JF, Tien RD, Osumi AK, et al. Cerebral phaeohyphomycosis complicated with brain abscess: A case report. Zhonghua Yi Xue Za Zhi (Taipei) 1995; 55: 491-495.
17. Groll AH, Giri N, Petraitis V, et al. Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system. J Infect Dis 2000; 182: 274-282.
18. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature. Mycopathologia 2001; 150: 101-115.
19. Johnson LB, Kauffman CA. Voriconazole: A new triazole antifungal agent. Clin Infect Dis 2003; 36: 630-637.
20. Drew RH, Perfect JR. Flucytosine. In: Yu VL, Merigan Jr TC, Barriere SL (eds). Antimicrobial Therapy and Vaccines, 1st edn. Baltimore: Williams & Wilkins, 1999: 1170-1184.
21. Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990; 23: 577-586.
22. Groll AH, Walsh TJ. Azoles: Triazoles. In: Yu VL, Merigan Jr TC, Barriere SL (eds). Antimicrobial Therapy and Vaccines, 1st edn. Baltimore: Williams & Wilkins, 1999: 1158-1170.
23. Dixon DM, Walsh TJ, Merz WG, McGinnis MR. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis 1989; 11: 515-525.